Us Burden of Illness Associated With Adjuvant Therapy for Stage I-Iii Melanoma

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.1247
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Considering Adjuvant Therapy for Stage II Melanoma

Cancer
Cancer ResearchOncology
2019English

Adjuvant Therapy: Melanoma

Journal of Skin Cancer
DermatologyOncology
2011English

Postoperative Adjuvant Therapy for Advanced Carcinoma of Tongue (Stage Iii and Iv)

Japanese jornal of Head and Neck Cancer
2002English

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial

The Lancet
Medicine
2008English

Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer

Current Oncology
Oncology
2014English

Update on Adjuvant Melanoma Therapy

Current Opinion in Oncology
Cancer ResearchOncology
2018English

P-0218 * Timing and Regimens of Adjuvant Therapy for Resected Stage Ii and Iii Colon Cancer

Annals of Oncology
MedicineOncologyHematology
2014English

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

Journal of Immunology Research
MedicineAllergyImmunology
2016English

Audiovestibular Dysfunction Associated With Adoptive Cell Therapy for Melanoma

Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy